Shionogi & Co logo

4507 - Shionogi & Co News Story

¥6043 -33.0  -0.5%

Last Trade - 07/08/20

Sector
Healthcare
Size
Large Cap
Market Cap £13.23bn
Enterprise Value £10.73bn
Revenue £2.25bn
Position in Universe 67th / 3862

U.S. FDA approves GSK unit's drug to treat infants and children with HIV

Fri 12th June, 2020 7:59pm
June 12 (Reuters) - The U.S. Food and Drug Administration
has approved a drug to treat infants and children with HIV, with
the drug having been developed by drugmaker GlaxoSmithKline's
 GSK.L  HIV drugs division ViiV Healthcare, the FDA and the GSK
unit said.
    The FDA said on Friday it was granting Viiv the approval of
Tivicay and Tivicay PD tablets "for suspension to treat HIV-1
infection in pediatric patients at least four weeks old and
weighing at least 3 kgs in combination with other antiretroviral
treatments".
    The drug is currently under review by the European Medicines
Agency, ViiV, in which Pfizer  PFE.N  and Shionogi  4507.T  have
small stakes, said in a separate statement.

 (Reporting by Kanishka Singh in Bengaluru
Editing by Chizu Nomiyama)
 ((Kanishka.Singh@thomsonreuters.com; +91 8061822801;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.